Trial Profile
The effect of Rapamycin on vaginal adenosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Vaginal diseases; Vulvovaginal cancer
- Focus Therapeutic Use
- 24 Feb 2016 Status changed from not yet recruiting to completed.
- 19 Aug 2013 New trial record